HOME >> MEDICINE >> NEWS
High blood pressure drug promotes new blood vessel growth in lab animals, providing potential 'angiogenesis' treatment

DALLAS, June 15 -- A drug used to lower high blood pressure can stimulate the growth of new blood vessels in laboratory animals.

The findings, reported in today's Circulation: Journal of the American Heart Association, suggest that the drug, quinaprilat, may prove useful for treating people with severe chest pain (angina) and others at high risk of suffering a heart attack, says the study's senior author Jeffrey M. Isner, M.D., professor of medicine and pathology at Tufts University School of Medicine in Boston.

Quinaprilat, marketed as Acupril, is one of several drugs known as angiotensin-conversion-enzyme (ACE) inhibitors, which are used primarily to treat high blood pressure and congestive heart failure. These drugs block the activation of angiotensin, which in its active form causes blood vessels to constrict. When blood vessels are constricted, the heart has to pump harder to force blood through the body.

"The study demonstrates an unexpected function of a class of drugs that is commercially available and already has been shown to be safe to use. Quinaprilat deserves to be investigated for its potential use for promoting blood vessel growth," says Isner.

The study findings may explain previous reports that ACE inhibitors can benefit individuals who have reduced blood flow to their hearts that can cause chest pain, or angina, says Isner.

"One reason for the interest in this approach is that ACE inhibitors are drugs that can be taken orally," he adds. "If they work out for this kind of application, they would be easy for patients to use and potentially would be among the simplest strategies one could devise for promoting new blood vessel formation."

The growth of new blood vessels is called angiogenesis. In recent years, scientists have focused considerable attention on drugs and natural molecules in the body that promote or inhibit angiogenesis. Pro-angiogenesis treatments also could help people when leg blood vessels are ob
'"/>

Contact: Karen Hunter
khunter@heart.org
214-706-1330
American Heart Association
14-Jun-1999


Page: 1 2 3 4

Related medicine news :

1. A marker for new blood vessel formation in tumors
2. Acupuncture found to lower elevations in blood pressure
3. Diagnostic test for range of blood disorders on the horizon
4. Research suggests possible blood test for multiple sclerosis
5. Epstein-Barr virus protein crucial to its role in blood cancers
6. Simple blood test may help to predict cardiovascular risk in older women
7. Drug that hinders blood vessel growth under study in ovarian cancer
8. Laughter helps blood vessels function better
9. St. Johns wort amplifies effect of blood thinner Plavix
10. Latest findings on genetic blood disorder Cooleys Anemia
11. Can routine commercial cord blood banking be scientifically and ethically justified?

Post Your Comments:
(Date:9/2/2015)... ... 03, 2015 , ... The Aspen Clinic (TAC), located in Basalt, ... kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, ... mind-body approach to fitness - we are much more than a gym. Our ...
(Date:9/2/2015)... ... September 03, 2015 , ... One can hardly argue against the fact ... do laptops and personal computers. These devices are being used as GPS, to make ... of mobile dating apps, STD positive singles can now join the prestigious social ranks ...
(Date:9/2/2015)... , ... September 03, 2015 , ... ... to determine who among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, health ... health care. This year, that process led the magazine to tap the National ...
(Date:9/2/2015)... ... September 02, 2015 , ... Chris Harrison of Harrison’s ... “It was a simple decision, really,” says Chris. “We have a lot of repeat ... the brands that work best for them—so we’ve given them the convenience of ordering ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading ... two leaders who will deliver keynote presentations at the upcoming Digital Healthcare Innovation ... Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the morning ...
Breaking Medicine News(10 mins):Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3
(Date:9/2/2015)... Sept. 2, 2015 About Neuroendovascular Coil ... to treat an unruptured and ruptured brain aneurysm ... treatment is either known as an endovascular coiling ... coil blocks the blood flow in an aneurysm. ... general anaesthesia by an interventional neuroradiologist using fluoroscopic ...
(Date:9/2/2015)... BOULDER, Colo. , Sept. 2, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Securities Healthcare Conference in Boston.  The public is ... webcast on the Array BioPharma website.Event: Wells Fargo ... , Thursday, September 10, 2015Time:  , 10:20 a.m. ...
(Date:9/2/2015)... Transaction Highlights: ... profitable specialty products , Expands pipeline with ... 11 product applications pending at the FDA, of ... Provides medium and longer term growth potential with ... substances , Adds development expertise in difficult ...
Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6
Cached News: